Previous
Hellas Verona
Juventus
4:00 PM GMT
Game Details
Arsenal
Aston Villa
4:30 PM GMT
Game Details
Borussia Dortmund
VfL Wolfsburg
6:00 PM GMT
Game Details
AJ Auxerre
Paris Saint-Germain
7:00 PM GMT
Game Details
Athletic Bilbao
Barcelona
7:30 PM GMT
Leg 1
Game Details
Mexico
Guatemala
ESPN3 10:00 PM GMT
Game Details
New York City FC
Houston Dynamo
11:00 PM GMT
Game Details
United States
South Korea
11:30 PM GMT
Game Details
Next

Who could be leaving Chelsea?

Chelsea
Read

Vilanova to undergo further treatment

Barcelona coach Tito Vilanova will return to New York this week for further medical attention following his cancer scare.

• Tomas: Neymar and Silva
• Messi bemoans absence

Vilanova, 44, had planned to have the treatment during the summer but he has confirmed he has brought it forward after Barca won their fourth Primera Division title in five years with three games to spare.

Having spent two months in New York earlier this season, when he underwent radiotherapy and chemotherapy treatment, Vilanova went back a fortnight ago for follow up tests. It is planned that he will only be away from the club from Monday to Friday.

A statement on the club's official website said: "Tito Vilanova has confirmed at a press conference that he will have further treatment for cancer next week in New York. The pioneering treatment has been developed at a specialised centre and is proving particularly effective.

"It was originally planned for this summer but as Barca has now clinched the league title it has been advanced to next week. Tito Vilanova will be away from Barcelona from Monday to Friday."

Barca play host to Real Valladolid on Sunday before completing their season against Espanyol and Malaga.

Information from the Press Association was used in this report.

Comments

Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.